BioMarin Reports Second Quarter 2026 Financial and Operating Results
Go back to BioMarin Reports Second Quarter 2026 Financial and Operating Results| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 61.46 +1.55 (2.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.91 | 52 Week High | $108.96 | |||
| Open | $60.46 | 52 Week Low | $62.12 | |||
| Day High | $61.67 | P/E | N/A | |||
| Day Low | $58.89 | EPS | $-1.27 | |||
| Volume | 3,452,612 | |||||
